Voyager Therapeutics Announces Publication Demonstrating Novel AAV Capsid for Blood-Brain Barrier Transport

Voyager Therapeutics announced the publication of data in Molecular Therapy demonstrating the ability of alkaline phosphatase (ALPL) to transport a no...
Home/KnloSights/Clinical Trial Updates/Voyager Therapeutics Announces Publication Demonstrating Novel AAV Capsid for Blood-Brain Barrier Transport